Skip to main content
Content Medically Reviewed & Updated: July 19, 2026 Call 24/7: 1-800-400-1805
1-800-400-1805 Free Case Review
Sign In Join Free

comparing treatment centers - what metrics actually matter when youre looking at options

Family · · 2,829 views
So my dad got his diagnosis in March and I spent weeks looking at different centers before we landed on Northwestern. I have a nursing background so I was kind of obsessive about this but honestly I think some of what I learned might help people actually figure out what to look at instead of just picking the closest place or whoever calls back first.

First thing, don't just look at 5-year survival rates by themselves because they're all over the place depending on how they define their patient population and stage mix. Northwestern publishes their median overall survival broken down by stage, which matters because stage IV patients have a different baseline than stage II. Ask centers directly for their median OS for your specific stage, not just their general numbers.

Volume is real. Centers doing 20+ meso cases a year tend to have better outcomes than the ones doing 3 or 4. That's not magic, that's just practice. Ask how many pleural meso patients they've treated in the last two years specifically.

The multidisciplinary team piece is critical. My dad saw oncology, thoracic surgery, pulmonology, and palliative care all in one clinic visit. Some places you have to coordinate that yourself which is exhausting when you're already dealing with a stage IV diagnosis. Ask if they have a dedicated meso tumor board.

Also ask about their approach to extrapleural pneumonectomy versus pleurectomy plus decortication. Different centers favor different surgeries and the evidence is honestly mixed, but you want to know they're thinking about what's right for your specific person, not just doing the same thing for everyone.

Clinical trial access. Northwestern had me sign consent paperwork for like four different trials before my dad was even eligible for any of them, just so we'd be ready if something opened up. That kind of infrastructure matters.

And honestly... call them and see how long it takes to get a response. If they take three weeks to return a call when your parent just got diagnosed with stage IV cancer, that tells you something about their operation. We got a callback from Northwestern within two hours on a Friday afternoon.

9 Replies

Veteran
Yeah, this is solid stuff. The volume metric especially resonates with me because when I was looking at options after my surgery in December, I asked one center how many cases they'd done and they couldn't even give me a straight answer. That right there told me everything I needed to know.
Veteran
Good breakdown. One thing I'd add from my own screening at VA hospitals - ask if they've got pulmonary function test data from their own patients post-surgery. That told me more about quality of life outcomes than any survival stat. Northwestern had those numbers ready to go.
Patient
Man this is exactly the kinda stuff people need to hear. I'm stage I so different ballgame than your dad but I went through picking a place too and yeah, some of those questions made all the difference.

The volume thing really stuck with me. My surgeon at Henry Ford said straight up that they do enough meso cases that they've basically dialed in what works, and I could tell the difference when I talked to some smaller hospitals that were treating me like I was a weird car they'd never seen before. Just seemed less confident, you know? Like they were looking stuff up between appointments.

What really helped me was asking about their EPP vs PD approach because that was THE decision for me. My doc laid out why he thought pleurectomy with decortication made more sense for my stage and my lung function instead of just defaulting to the bigger surgery. That told me he was actually thinking about me as a person and not just running the same playbook on everyone.

Also gotta say the multidisciplinary thing is huge. After my surgery in February I had chemo lined up fast, but because my team was already talking to each other they caught some stuff about my heart function that mattered for which drugs I could handle. Not sure that happens as smooth when you're coordinating five different departments yourself while you're freaking out.

The callback thing your dad experienced, that matters more than people think. You're already scared outta your mind and if a place makes you wait around for answers that's not the vibe you want when things get rough.

Glad your nursing background helped. Sounds like your dad landed in good hands at Northwestern.
Family
This is such a solid breakdown and yeah, the volume thing is real. We went through this exact process with my dad and I kept hitting this wall where centers would cite their survival stats but wouldn't actually break it down by stage. Stage IV is a completely different ballgame and you're right that some places lump everyone together to make their numbers look better.

One thing I'd add from our experience: ask about their palliative care integration from day one, not just when curative options run out. My dad's oncologist at Northwestern actually brought in the palliative team during his first visit even though we were initially pursuing aggressive treatment. That felt weird at the time but honestly it changed everything about how we managed his side effects and what our conversations looked like. A lot of centers treat palliative care like you failed treatment, when really it's just... managing the person in front of you.

The tumor board thing cannot be overstated. Watching them actually discuss my dad's case in real time with surgery, oncology, and pulmonology all in the room asking questions of each other was eye opening. It's not just a checkbox, you can feel the difference in how coordinated the care actually is.

Also the clinical trial piece... we did end up on a trial starting in June and it bought us some time. Northwestern was very clear about what the realistic expectations were but having access to something beyond standard chemotherapy mattered for my dad's sense of agency. Not every center has that pipeline.

Your point about response time is everything. We also got a callback within hours and that initial responsiveness kind of set the tone for how we were treated throughout. It sounds small but when you're panicking it matters.
Veteran
Got a solid post here M. Wish I'd had this kind of roadmap back in June when the VA doc called me in after that routine screening. Stage II pleural they said and I'll be honest, I was all business at first. Didn't really know what questions to ask.

We went with the VA system here in Norfolk initially because that's how I roll, but then my daughter pushed back hard. She's got medical background too and she started asking around about volume and outcomes. Turned out our local VA thoracic guy was solid but only handled maybe 4-5 meso cases a year. Ended up getting referred to a center that was doing closer to 30 cases annually and the difference in how they approached the pleurectomy in August was noticeable. They had a whole protocol already built out instead of everyone kind of figuring it out as they went.

The multidisciplinary piece you mentioned is exactly right. Before my surgery I saw four different specialists in one afternoon and they all talked to each other in real time. That wasn't happening at the first place we looked at. You end up chasing people down yourself when they're not coordinated and that's exhausting when you're already dealing with this stuff.

One thing that mattered to me was asking point blank about their complication rates and what happens if something goes sideways post-op. Not just survival stats but actual operational stuff. How many times have they had to go back in. How's their ICU support. That tells you whether they're being straight with you or just selling the good numbers.

Recovery's been solid so far. Finished chemo in November and we're watching things close. But I'm convinced getting to the right team early made all the difference.
Family
Your daughter sounds like she had the right instinct pushing back on that. The VA system can be solid but yeah, volume is everything with meso and some VA centers just don't have the caseload. Did she end up getting you referred out to somewhere with higher volume, or are you still working with Norfolk? Stage II is a different ballgame than what my dad's dealing with, so you might have more surgical options on the table which is actually good news if you can get in front of the right team.
Patient
This is incredibly detailed and exactly the kind of practical breakdown I wish I'd had when we were making decisions about my HIPEC consult. The question about median OS by stage is something I'm definitely asking my surgical team at Cleveland Clinic next week.
Medical ✓ Expert Response
This is one of the most practical posts I've seen on this forum and I want to add a few things from the clinical side.

The EPP versus P/D question you raised is worth expanding on. The MARS trial (2011) and some follow-up data have genuinely muddied the waters on EPP, and centers that are still defaulting to EPP for everyone without a real conversation about functional status and surgical margins are worth questioning. Ask specifically what their 30-day and 90-day post-surgical mortality rates are for each procedure. Some centers won't tell you. The ones that will, and can explain the numbers, are usually the ones doing this work carefully.

On tumor boards, I'd push a little further than just asking if one exists. Ask how often it meets and whether your dad's case will actually be presented, not just reviewed informally. There's a difference. When I was doing a fellowship rotation at UCSF in 2014, we had a dedicated thoracic malignancy board that met every Tuesday at 7am and every case was formally presented with imaging. That structure changes how decisions get made.

The trial infrastructure point you made is something families almost never think to ask about. Consenting early so you're ready if eligibility opens up, that's a sign of a team that's thinking ahead.

One thing I'd add: ask about their tissue banking program. If your dad's tumor has already been biopsied, where does that tissue go and can it be accessed for future molecular profiling as new assays become available. This comes up more than people expect.

Talk to your own oncologist about any of this before making decisions, because your dad's specific pathology and functional status will matter more than any general framework.
3 found this helpful
Family
The MARS data is exactly why I was pushing back on our first surgeon's recommendation. He wanted EPP across the board and when I asked about my dad's functional status and comorbidities, it felt like an afterthought in his decision tree rather than the driver. Northwestern's team actually walked through the margin assessment with imaging first, then discussed which approach made sense for him specifically. I think patients need to hear this from someone with your clinical credibility because a lot of people will just defer to whatever the surgeon says without understanding there's actually legitimate debate here. Did you see centers that were doing better with one approach versus the other, or is it really just case-by-case at this point?

Share Your Experience

Sign in or create a free account to share your experience.

Sign In Create Account

Discussions in this community are for informational and emotional support purposes only. They do not constitute legal advice, medical advice, or an attorney-client relationship. Always consult a qualified professional for advice specific to your situation. Community Guidelines

Call Now: (800) 400-1805 Free Case Review • Available 24/7